Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · Real-Time Price · USD
101.06
-0.07 (-0.07%)
At close: Dec 5, 2025, 4:00 PM EST
101.27
+0.21 (0.20%)
After-hours: Dec 5, 2025, 6:23 PM EST
Exact Sciences Stock Forecast
Stock Price Forecast
According to 16 professional analysts, the 12-month price target for Exact Sciences stock ranges from a low of $46 to a high of $105. The average analyst price target of $76.38 forecasts a -24.42% decrease in the stock price over the next year.
Price Target: $76.38 (-24.42%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Exact Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 11 | 5 |
| Buy | 7 | 7 | 7 | 7 | 7 | 5 |
| Hold | 2 | 2 | 4 | 4 | 3 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 22 | 22 | 21 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $85 → $105 | Strong Buy → Hold | Downgrades | $85 → $105 | +3.90% | Nov 25, 2025 |
| Benchmark | Benchmark | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 24, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $90 → $105 | Strong Buy → Hold | Downgrades | $90 → $105 | +3.90% | Nov 24, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $85 → $105 | Buy → Hold | Downgrades | $85 → $105 | +3.90% | Nov 21, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 21, 2025 |
Financial Forecast
Revenue This Year
3.29B
from 2.76B
Increased by 19.40%
Revenue Next Year
3.74B
from 3.29B
Increased by 13.51%
EPS This Year
-0.72
from -5.59
EPS Next Year
0.33
from -0.72
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.4B | 4.0B | ||||
| Avg | 3.3B | 3.7B | ||||
| Low | 3.2B | 3.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 23.1% | 20.0% | ||||
| Avg | 19.4% | 13.5% | ||||
| Low | 14.5% | 3.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.59 | 0.83 | |||
| Avg | -0.72 | 0.33 | |||
| Low | -0.98 | -0.24 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.